Abstract
OBJECTIVES--To determine the use of renal replacement therapy by ethnic origin and to ascertain the variation in provision of such therapy and to relate this to the distribution of ethnic minority populations. DESIGN--Analysis of retrospective and cross sectional data from 19 renal units. SETTING--All four Thames regional health authorities. SUBJECTS--Patients resident in the Thames regions who were accepted as new patients for renal replacement therapy during 1991 and 1992 and the patients who were already undergoing such treatment between December 1992 and April 1993. MAIN OUTCOME MEASURES--Rates of acceptance for and prevalence of renal replacement therapy among white, black, and Asian people. RESULTS--The average annual acceptance rates per million in 1991-2 were 61 for white people, 175 for black people, and 178 for Asians, and the prevalences per million were 351, 918, and 957 respectively. The relative risks increased with age. A threefold increase in the acceptance rate occurred in people aged under 55 in both the black and Asian populations, suggesting that the higher rates are probably not due to factors related to access alone. Treatment rates varied considerably among districts, reflecting both the distribution of ethnic minority populations and access to services. CONCLUSION--Black and Asian people receive and have a greater need for renal replacement therapy, and the need will increase as these populations age. These findings have important implications for the provision of renal services in districts with a high proportion of ethnic minorities and for the management of diabetes mellitus and hypertension, two important causes of end stage renal failure in these populations.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burden A. C., McNally P. G., Feehally J., Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med. 1992 Aug-Sep;9(7):641–645. doi: 10.1111/j.1464-5491.1992.tb01860.x. [DOI] [PubMed] [Google Scholar]
- Cowie C. C., Port F. K., Wolfe R. A., Savage P. J., Moll P. P., Hawthorne V. M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989 Oct 19;321(16):1074–1079. doi: 10.1056/NEJM198910193211603. [DOI] [PubMed] [Google Scholar]
- Cruickshank J. K., Cooper J., Burnett M., MacDuff J., Drubra U. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet. 1991 Oct 5;338(8771):842–847. doi: 10.1016/0140-6736(91)91501-k. [DOI] [PubMed] [Google Scholar]
- Eggers P. W., Connerton R., McMullan M. The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev. 1984 Spring;5(3):69–88. [PMC free article] [PubMed] [Google Scholar]
- Feest T. G., Mistry C. D., Grimes D. S., Mallick N. P. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. BMJ. 1990 Oct 20;301(6757):897–900. doi: 10.1136/bmj.301.6757.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glover G. R. Sex ratio errors in census data. BMJ. 1993 Aug 21;307(6902):506–506. doi: 10.1136/bmj.307.6902.506-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hiatt R. A., Friedman G. D. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health. 1982 Aug;72(8):829–833. doi: 10.2105/ajph.72.8.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mather H. M., Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985 Oct 19;291(6502):1081–1084. doi: 10.1136/bmj.291.6502.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McClellan W., Tuttle E., Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1988 Oct;12(4):285–290. doi: 10.1016/s0272-6386(88)80221-x. [DOI] [PubMed] [Google Scholar]
- McGeown M. G. Prevalence of advanced renal failure in Northern Ireland. BMJ. 1990 Oct 20;301(6757):900–903. doi: 10.1136/bmj.301.6757.900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKeigue P. M., Shah B., Marmot M. G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991 Feb 16;337(8738):382–386. doi: 10.1016/0140-6736(91)91164-p. [DOI] [PubMed] [Google Scholar]
- Pazianas M., Eastwood J. B., MacRae K. D., Phillips M. E. Racial origin and primary renal diagnosis in 771 patients with end-stage renal disease. Nephrol Dial Transplant. 1991;6(12):931–935. doi: 10.1093/ndt/6.12.931. [DOI] [PubMed] [Google Scholar]
- Rostand S. G., Kirk K. A., Rutsky E. A., Pate B. A. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982 May 27;306(21):1276–1279. doi: 10.1056/NEJM198205273062106. [DOI] [PubMed] [Google Scholar]
- Samanta A., Burden A. C., Feehally J., Walls J. Diabetic renal disease: differences between Asian and white patients. Br Med J (Clin Res Ed) 1986 Aug 9;293(6543):366–367. doi: 10.1136/bmj.293.6543.366-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shulman N. B., Hall W. D. Renal vascular disease in African-Americans and other racial minorities. Circulation. 1991 Apr;83(4):1477–1479. doi: 10.1161/01.cir.83.4.1477. [DOI] [PubMed] [Google Scholar]
- Thompson E. J. Underenumeration in the 1991 census. BMJ. 1993 Sep 25;307(6907):803–803. doi: 10.1136/bmj.307.6907.803-b. [DOI] [PMC free article] [PubMed] [Google Scholar]